Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 6 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| ACTUATE THERAPEUTICS, INC. | 71,428 | reported | 27 Jun 2025 | tx 5+142,856−24,999 |
| Lantern Pharma Inc. | 27,328 | reported | 02 Sept 2022 | tx 6+65,076−6,445 |
| IN8BIO, INC. | 0 | reported | 02 May 2025 | tx 6+2,922,166−1,148,482 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Jun 2025 | PURCHASE | ACTUATE THERAPEUTICS, INC. | 71,428 | 7.00 USD | |
| 27 Jun 2025 | PURCHASE | ACTUATE THERAPEUTICS, INC. | 71,428 | 0.00 USD | deriv |
| 02 May 2025 | OTHER | IN8BIO, INC. | 574,241 | — | deriv |
| 02 May 2025 | OTHER | IN8BIO, INC. | 574,241 | — | deriv |
| 02 May 2025 | PURCHASE | IN8BIO, INC. | 1,148,482 | — | derivfirst after silence |
| 02 Sept 2022 | EXERCISE | Lantern Pharma Inc. | 6,438 | 1.03 USD | |
| 02 Sept 2022 | SALE | Lantern Pharma Inc. | 1,275 | 5.20 USD | |
| 02 Sept 2022 | SALE | Lantern Pharma Inc. | 5,170 | 5.20 USD | |
| 02 Sept 2022 | EXERCISE | Lantern Pharma Inc. | 26,100 | 1.03 USD | |
| 02 Sept 2022 | EXERCISE | Lantern Pharma Inc. | 26,100 | 0.00 USD | deriv |
| 02 Sept 2022 | EXERCISE | Lantern Pharma Inc. | 6,438 | 0.00 USD | deriv |
| 16 Aug 2022 | PURCHASE | IN8BIO, INC. | 217,891 | 1.90 USD | |
| 16 Aug 2022 | PURCHASE | IN8BIO, INC. | 1,349,218 | 1.90 USD | |
| 16 Aug 2022 | PURCHASE | IN8BIO, INC. | 206,575 | 1.90 USD |
1 purchase reported after at least 12 months of silence — most recent on 02 May 2025.